Description
The AbC-19 Rapid Test produces a test result within 20 minutes, helping control and contain Covid19.
The Abc-19 rapid test is produced by the UK-RTC (UK-Rapid Consortium) and have been purchased by the UK Government as part of the endeavour to keep life, business and wellbeing moving onwards through this pandemic. The ability to rapid test means that healthcare workers can safely upkeep productivity where it’s so vitally needed, as opposed to losing time waiting for 48hrs+ for a general Covid19 test.
The “AbC-19TM Rapid Test”, uses a small drop of blood from a finger-prick, and shows results in 20 minutes, without the need to go to a specialised laboratory.
Currently restricted sale for commercial use only
The test can be administered by healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers, at the point-of-care. It has already received the “CE mark”, which indicates health and safety conformity for goods sold in the UK and EU.
The test is 99.40% accurate, following production of tens of thousands of tests across multiple production scale batches. Testing was performed at Ulster University and at the laboratories of Abingdon Health.
The test will make it possible to build a swift and clear picture of how the virus has spread throughout the UK population.
It will also be able to help establish the effectiveness of any vaccine which provides protection by creating new antibodies. This information will be critical to managing current and future outbreaks of COVID-19.
Mass production is already under way. The antibody test will be rolled out under the government’s COVID-19 surveillance studies to help build a picture of how the virus has spread across the country. Surveillance studies are vital to develop our understanding of how antibodies work.